People
In addition to the impact on conferences and large meetings, many companies have implemented restrictions on face-to-face meetings between sales reps and clients.
Doudna announced she is converting a 2,500-square-foot scientific lab at Berkeley’s Innovative Genomics Institute into a lab for testing for the novel coronavirus that causes COVID-19.
First uses are envisioned as treatments for severely ill coronavirus patients and individuals at high risk of contracting the disease, including healthcare professionals.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 30, 2020.
Pioneering new technologies for resetting the immune system, developing novel, first-in-class therapies for inflammatory and immunological diseases
One of the key takeaways from BIO-Europe Spring 2020 was that there is a keen need for greater collaboration and communications among the biotech community, government, non-governmental organizations and the public.
Troubled Unum Therapeutics announced its fourth quarter and full-year financial report yesterday. Among the news was that it is considering seemingly every possible strategic option, including a sale or merger.
A summary of daily biopharma industry news. Please check out stories that are trending on March 26, 2020.
A summary of daily biopharma industry news. Please check out stories that are trending on March 25, 2020.
“These kinds of situations remind people how important diagnostics are,” Hawkins told BioSpace in an interview.
PRESS RELEASES